Literature DB >> 23983890

Fulminant demyelinating diseases.

Megan R Rahmlow1, Orhun Kantarci.   

Abstract

Fulminant demyelinating disease is a heading that covers acute disseminated encephalomyelitis and its variant acute hemorrhagic leukoencephalitis (Hurst disease), severe relapses of multiple sclerosis (MS), variants of MS (tumefactive MS, Marburg variant, Balo concentric sclerosis, myelinoclastic diffuse sclerosis), and neuromyelitis optica-spectrum disorders associated with aquaporin autoimmunity. These categories of inflammatory demyelinating disease often prompt hospital admission and many necessitate intensive care monitoring due to the aggressive nature of the illness and associated neurologic morbidity. In this review, we highlight the discriminating clinical, radiographic, and pathologic features of these disorders. Acute management is often accomplished with use of high-dose intravenous steroids and plasma exchange. Aggressive disease may respond to immunosuppression. Prognosis for recovery varies among the disorders but most patients improve. Factors influencing outcome are also discussed.

Entities:  

Keywords:  ADEM; Marburg; fulminant MS; neuromyelitis optica; tumefactive MS

Year:  2013        PMID: 23983890      PMCID: PMC3726114          DOI: 10.1177/1941874412466873

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  69 in total

1.  Decompressive hemicraniectomy for tumefactive demyelination with transtentorial herniation: observation.

Authors:  Brian T Ragel; Daniel R Fassett; J Richard Baringer; Samuel R Browd; Andrew T Dailey
Journal:  Surg Neurol       Date:  2006-06

2.  Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.

Authors:  C Costanzi; M Matiello; C F Lucchinetti; B G Weinshenker; S J Pittock; J Mandrekar; P Thapa; A McKeon
Journal:  Neurology       Date:  2011-08-03       Impact factor: 9.910

3.  Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin.

Authors:  D J Sahlas; S P Miller; M Guerin; M Veilleux; G Francis
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

4.  High dose cyclophosphamide treatment in Marburg variant multiple sclerosis A case report.

Authors:  Kenkichi Nozaki; Nada Abou-Fayssal
Journal:  J Neurol Sci       Date:  2010-06-25       Impact factor: 3.181

5.  Fulminant form of acute disseminated encephalomyelitis: successful treatment with hypothermia.

Authors:  T Takata; M Hirakawa; M Sakurai; I Kanazawa
Journal:  J Neurol Sci       Date:  1999-05-01       Impact factor: 3.181

6.  Beneficial plasma exchange response in central nervous system inflammatory demyelination.

Authors:  Setty M Magaña; B Mark Keegan; Brian G Weinshenker; Bradley J Erickson; Sean J Pittock; Vanda A Lennon; Moses Rodriguez; Kristine Thomsen; Stephen Weigand; Jay Mandrekar; Linda Linbo; Claudia F Lucchinetti
Journal:  Arch Neurol       Date:  2011-03-14

7.  Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?

Authors:  Su-Hyun Kim; Woojun Kim; Xue Feng Li; In-Ja Jung; Ho Jin Kim
Journal:  Mult Scler       Date:  2012-02-21       Impact factor: 6.312

8.  Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.

Authors:  J J Kepes
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

9.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

10.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

View more
  13 in total

1.  Tumefactive demyelination of the spinal cord: a case report.

Authors:  E Kantorová; J Marcinek; K Zeleňák; K Kantor; J Michalik; Š Sivák; E Kurča; L Plank
Journal:  Spinal Cord       Date:  2015-06-30       Impact factor: 2.772

2.  Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination.

Authors:  Hadia R Ahmad; Victoria M Timmermans; Tarek Dakakni
Journal:  Am J Case Rep       Date:  2022-06-19

3.  Atypical presentations of acute disseminated encephalomyelitis (ADEM) in HIV infection.

Authors:  Ansuya Naidoo; Hoosain Paruk; Bhupendra Bhagwan; Anand Moodley
Journal:  J Neurovirol       Date:  2016-09-29       Impact factor: 2.643

4.  A Case of Acute Disseminated Encephalomyelitis in a Middle-Aged Adult.

Authors:  Nicole Mahdi; Peter A Abdelmalik; Mark Curtis; Barak Bar
Journal:  Case Rep Neurol Med       Date:  2015-06-09

5.  Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis.

Authors:  Özlem Yildiz; Refik Pul; Peter Raab; Christian Hartmann; Thomas Skripuletz; Martin Stangel
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

6.  Bilateral abducens nerve palsy in an infant case of fulminant acute disseminated encephalomyelitis: a case report.

Authors:  Zhiliang Yang; Guilian Sun
Journal:  BMC Ophthalmol       Date:  2016-10-26       Impact factor: 2.209

7.  Multiple Sclerosis Presenting as a Delirium: A Case Report.

Authors:  Nastaran Mahboobi; Silke Nolden-Hoverath; Olaf Rieker; Hartmut Bauer
Journal:  Med Princ Pract       Date:  2015-06-04       Impact factor: 1.927

8.  Adult onset acute disseminated encephalomyelitis: A case report.

Authors:  Nizar Almaghrabi; Abeer Saab
Journal:  Radiol Case Rep       Date:  2021-07-02

9.  Haemorrhagic encephalitis in the garb of scrub typhus.

Authors:  Saurabh Gaba; Swati Garg; Monica Gupta; Rekha Gupta
Journal:  BMJ Case Rep       Date:  2020-08-27

10.  Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect.

Authors:  Frederico Carvalho de Medeiros; Lucas Alverne Freitas de Albuquerque; Jose Eymard Homem Pittella; Renata Brant de Souza; Antonio Pereira Gomes Neto; Paulo Pereira Christo
Journal:  Case Rep Neurol Med       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.